Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Avidity of anti-phospholipid antibodies in relation to their levels

L. FialovÁ, O. KuchaŘ, M. PetrÁČkovÁ, I. Malbohan, T. Zima

. 2020 ; 45 (2) : 136-143. [pub] 20200727

Jazyk angličtina Země Polsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21010262

Introduction: The heterogeneity of anti-phospholipid antibodies can be manifested not only in different antigenic specificities, but also in their avidities. The aim of the study was to investigate the relationship between anti-cardiolipin antibody (aCL) IgG avidities and levels within the range of their titres, from very low to high ones. Material and methods: We analyzed 78 serum samples from 60 patients by ELISA with chaotropic agents, using urea concentration of 6 and 8 mol/l and single diluted serum samples. The changes of aCL levels and avidities were explored during a long-term follow-up in 14 patients. Results: The avidities of aCLs did not differ in the groups of patients classified according to aCL levels. The higher avidity antibodies predominated in our patients and the fluctuation of avidities in the longitudinal follow-up did not show significant differences. No relationship between aCL levels and their avidities was found. Conclusions: aCL avidities seem to have no relationship with aCL levels and high-avidity aCLs; the potentially deleterious effects might be present also in patients with low and extremely low aCL levels. Avidity of aCLs belongs to stable characteristics with insignificant changes in time.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21010262
003      
CZ-PrNML
005      
20210610095908.0
007      
ta
008      
210413s2020 pl f 000 0|eng||
009      
AR
024    7_
$a 10.5114/ceji.2020.97901 $2 doi
035    __
$a (PubMed)33456323
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a pl
100    1_
$a FialovÁ, Lenka $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic
245    10
$a Avidity of anti-phospholipid antibodies in relation to their levels / $c L. FialovÁ, O. KuchaŘ, M. PetrÁČkovÁ, I. Malbohan, T. Zima
520    9_
$a Introduction: The heterogeneity of anti-phospholipid antibodies can be manifested not only in different antigenic specificities, but also in their avidities. The aim of the study was to investigate the relationship between anti-cardiolipin antibody (aCL) IgG avidities and levels within the range of their titres, from very low to high ones. Material and methods: We analyzed 78 serum samples from 60 patients by ELISA with chaotropic agents, using urea concentration of 6 and 8 mol/l and single diluted serum samples. The changes of aCL levels and avidities were explored during a long-term follow-up in 14 patients. Results: The avidities of aCLs did not differ in the groups of patients classified according to aCL levels. The higher avidity antibodies predominated in our patients and the fluctuation of avidities in the longitudinal follow-up did not show significant differences. No relationship between aCL levels and their avidities was found. Conclusions: aCL avidities seem to have no relationship with aCL levels and high-avidity aCLs; the potentially deleterious effects might be present also in patients with low and extremely low aCL levels. Avidity of aCLs belongs to stable characteristics with insignificant changes in time.
655    _2
$a časopisecké články $7 D016428
700    1_
$a KuchaŘ, Oliver $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic
700    1_
$a PetrÁČkovÁ, Milada $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic
700    1_
$a Malbohan, Ivan $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic
700    1_
$a Zima, TomÁŠ $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic
773    0_
$w MED00173245 $t Central-European journal of immunology $x 1426-3912 $g Roč. 45, č. 2 (2020), s. 136-143
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33456323 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20210413 $b ABA008
991    __
$a 20210610095907 $b ABA008
999    __
$a ind $b bmc $g 1649754 $s 1130638
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 45 $c 2 $d 136-143 $e 20200727 $i 1426-3912 $m Central-European Journal of Immunology $n Cent.-Eur. J. Immunol. $x MED00173245
LZP    __
$a Pubmed-20210413

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...